New malaria vaccines put to the test in indonesian soldiers
NCT ID NCT03503058
First seen May 05, 2026 · Last updated May 07, 2026 · Updated 1 time
Summary
This study tested two experimental malaria vaccines (PfSPZ Vaccine and PfSPZ-CVac) in 345 healthy Indonesian soldiers deployed to a malaria-prone region. The goal was to see if the vaccines are safe and can prevent natural malaria infection. Participants received either a vaccine or a placebo, and researchers tracked how many got malaria during their deployment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Internal Medicine, Universitas Indonesia
Jakarta, 10430, Indonesia
-
Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology
Jakarta, 10430, Indonesia
Conditions
Explore the condition pages connected to this study.